# First in Men Study of Single Oral Doses of ASP1941 in Healthy Subjects

> **NCT01288885** · PHASE1 · COMPLETED · sponsor: **Astellas Pharma Inc** · enrollment: 76 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** ASP1941
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01288885
- **Lead sponsor:** Astellas Pharma Inc
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2007-05
- **Final completion:** 2007-05
- **Target enrollment:** 76 (ACTUAL)
- **Last updated:** 2011-02-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01288885

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01288885, "First in Men Study of Single Oral Doses of ASP1941 in Healthy Subjects". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT01288885. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*